SEC Form 4 · accession 0000921895-18-002602
Enveric Biosciences, Inc. · ENVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brent Kelton
Officer — Chief Executive Officer
Period of report
Sep 12, 2018
Accepted (ET)
Sep 14, 2018 · 4:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 93,176 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (Right to Buy)F1 | $1.45 | Sep 12, 2018 | A | 250,000 | A | — | — | Common Stock | 250,000 | 250,000 | D |
Explanation of responses
- F1The options vest on the first anniversary of the grant date. The options will expire on the sixth anniversary of the grant date.